In March 2025, the company declared new programs for any immediate-to-client supplying of its Wegovy weight loss drug. The company founded a completely new pharmacy, referred to as NovoCare, which would charge clients $499 monthly for entry to the drug, below 50 percent the price of the drug as a result of other pharmaceutical distribution networks